A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)

Completed

Plain-English translation of NCT03607422 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(196 sites)

United States

Total Skin and Beauty Derm Ctr /ID# 205129, Birmingham, Alabama

Medical Dermatology Specialist /ID# 205516, Phoenix, Arizona

Arizona Research Center, Inc. /ID# 205795, Phoenix, Arizona

The Dermatology Clinic of Arkansas /ID# 218749, Bryant, Arkansas

Arkansas Research Trials /ID# 218469, North Little Rock, Arkansas